305 related articles for article (PubMed ID: 34581863)
21. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors.
Gharaghani S; Khayamian T; Ebrahimi M
SAR QSAR Environ Res; 2013; 24(9):773-94. PubMed ID: 23863115
[TBL] [Abstract][Full Text] [Related]
23. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
24. 2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity.
Thakur A; Sharma B; Parashar A; Sharma V; Kumar A; Mehta V
J Biomol Struct Dyn; 2024; 42(1):148-162. PubMed ID: 36970779
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
Ambure P; Kar S; Roy K
Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
[TBL] [Abstract][Full Text] [Related]
26. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays.
Sahin K; Zengin Kurt B; Sonmez F; Durdagi S
J Biomol Struct Dyn; 2020 Jul; 38(11):3342-3358. PubMed ID: 31462153
[TBL] [Abstract][Full Text] [Related]
27. Alignment-independent 3D-QSAR and molecular docking studies of tacrine-4-oxo-4H-Chromene hybrids as anti-Alzheimer's agents.
Manouchehrizadeh E; Mostoufi A; Tahanpesar E; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():463-471. PubMed ID: 31170562
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
Azam MA; Thathan J
SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel benzofuran-based derivatives as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis, biological evaluation, molecular docking and 3D-QSAR investigation.
Abd El-Karim SS; Anwar MM; Ahmed NS; Syam YM; Elseginy SA; Aly HF; Younis EA; Khalil WKB; Ahmed KA; Mohammed FF; Rizk M
Eur J Med Chem; 2023 Nov; 260():115766. PubMed ID: 37678141
[TBL] [Abstract][Full Text] [Related]
30. 2D-SAR and 3D-QSAR analyses for acetylcholinesterase inhibitors.
Niu B; Zhao M; Su Q; Zhang M; Lv W; Chen Q; Chen F; Chu D; Du D; Zhang Y
Mol Divers; 2017 May; 21(2):413-426. PubMed ID: 28275924
[TBL] [Abstract][Full Text] [Related]
31. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
[TBL] [Abstract][Full Text] [Related]
32. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Zhang S; Hou B; Yang H; Zuo Z
Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327
[TBL] [Abstract][Full Text] [Related]
33. Computational Studies on Acetylcholinesterase Inhibitors: From Biochemistry to Chemistry.
Bagri K; Kumar A; Manisha ; Kumar P
Mini Rev Med Chem; 2020; 20(14):1403-1435. PubMed ID: 31884928
[TBL] [Abstract][Full Text] [Related]
34. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
Daoud I; Melkemi N; Salah T; Ghalem S
Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
[TBL] [Abstract][Full Text] [Related]
35. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
[TBL] [Abstract][Full Text] [Related]
36. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
37. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
[TBL] [Abstract][Full Text] [Related]
38. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
[TBL] [Abstract][Full Text] [Related]
39. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
Lee S; Barron MG
Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
[TBL] [Abstract][Full Text] [Related]
40. Three Dimensional Quantitative Structure Activity Relationship and Pharmacophore Modeling of Tacrine Derivatives as Acetylcholinesterase Inhibitors in Alzheimer's Treatment.
Ansari F; Ghasemi JB; Niazi A
Med Chem; 2020; 16(2):155-168. PubMed ID: 31092184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
